Newsroom | 220977 results

Sorted by: Latest

Health
-

Gustave Roussy et One Biosciences s'associent pour intégrer les technologies en cellule unique dans la pratique clinique au service de l'oncologie de précision

PARIS--(BUSINESS WIRE)--Gustave Roussy s'associe à One Biosciences, une techbio qui exploite la technologie en cellule unique (single cell) et l'intelligence artificielle pour développer des diagnostics de précision. Cette collaboration vise à démontrer plus avant la faisabilité et l'impact d’intégrer l'analyse transcriptomique en cellule unique dans le parcours de soins des patients. Gustave Roussy, premier centre de lutte contre le cancer en Europe, s'allie à One Biosciences pour exploiter le...
-

Gustave Roussy and One Biosciences Partner to Bring Single Cell to Clinical Practice for Precision Oncology

PARIS--(BUSINESS WIRE)--Gustave Roussy and One Biosciences announce partnership to bring single cell to clinical practice for precision oncology....
-

InterSystems IntelliCare Becomes the First AI-Native EHR to Achieve EU Medical Device Regulation Certification

BOSTON--(BUSINESS WIRE)--InterSystems, a creative data technology provider powering more than one billion health records globally, today announced that its electronic health record (EHR) solutions have been certified as Class IIa Medical Devices under Regulation (MDR) certification under Regulation (EU) 2017/745. This approval marks the first fully unified AI-native EHR to achieve MDR Class IIa certification in the European Union. This certification demonstrates that InterSystems AI-native EHR...
-

InterSystems IntelliCare wordt het eerste AI-native EPD dat de EU-certificering voor medische hulpmiddelen behaalt

BOSTON--(BUSINESS WIRE)--InterSystems, een leverancier van creatieve datatechnologie die wereldwijd meer dan een miljard medische dossiers voedt, heeft vandaag aangekondigd dat zijn oplossingen voor elektronische medische dossiers (EHR) zijn gecertificeerd als Klasse IIa Medische Hulpmiddelen onder Verordening (MDR) certificering onder Verordening (EU) 2017/745. Deze goedkeuring markeert de eerste volledig uniforme AI-native EHR die MDR Klasse IIa certificering behaalt in de Europese Unie. Deze...
-

Verici Dx Announces Publication Validating Pre-Transplant Gene Signature Test for Predicting Early Acute Rejection in Kidney Transplant Recipients

FRANKLIN, Tenn.--(BUSINESS WIRE)--Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, today announced the publication of a peer-reviewed clinical validation study of the Pre-Transplant Rejection Assessment (PTRA) test that stratifies patients undergoing deceased donor kidney transplantation as to their risk of acute rejection in the first two months post-transplant. The study, entitled “A Pre-Kidney Transplant Blood-Based Next-Generation Sequencing Assa...
-

CCS Unveils New Research at ISPOR 2026: Longitudinal Coaching and Education Sustain CGM Outcomes Beyond Initiation

ST. PETERSBURG, Fla.--(BUSINESS WIRE)--As healthcare providers and health plans grapple with growing continuous glucose monitoring (CGM) adoption and persistent gaps in diabetes outcomes alongside growing chronic care costs, a new research-driven poster from CCS is challenging the assumption that simply being prescribed a CGM device is enough. While CGM initiation is often associated with early improvements in glycemic control, new research from CCS suggests those improvements are not consisten...
-

Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of PreserVision AREDS3 eye vitamins, which combine the clinically proven AREDS2 nutrients recommended by the NEI to help reduce the risk of moderate-to-advanced AMD progression with a unique B-vitamin complex.* Built on decades of leadership in AREDS-based vitamins, PreserVision AREDS3 is the mos...
-

TransAct Technologies Announces Successful OEM Partnership with MedVantage

HAMDEN, Conn.--(BUSINESS WIRE)--TransAct Technologies Incorporated (Nasdaq: TACT) a leading provider of cloud-based software and integrated hardware solutions, today announced the continued success of its OEM partnership with MedVantage, a leading provider of operational solutions to healthcare and food service environments. Now in its third year, the partnership has driven significant adoption of TransAct’s purpose-built hardware and SaaS platform solutions bringing efficiency and visibility t...
-

IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX integrates SDMA into most common Catalyst chemistry profiles, enabling earlier detection of kidney disease through routine in‑clinic testing....
-

NationsBenefits and Harps Partner to Expand Flex Card Access for Rx and OTC Health Needs Across Mid-South and Ozark Communities

PLANTATION, Fla.--(BUSINESS WIRE)--NationsBenefits®, the leading healthcare fintech and benefits platform, today announced a new retail network integration with Harps, a premier 100% employee-owned supermarket chain serving communities across Arkansas, Kansas, Kentucky, Louisiana, Mississippi, Missouri, Oklahoma, and Tennessee. Through this integration, eligible health plan members can use their NationsBenefits Mastercard® Prepaid Flex Card* at more than 160 Harps locations to purchase approved...